CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
CRDL fundamentals
Cardiol Therapeutics (CRDL) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.0862 (YoY +35.19%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.0862
+35.19%
Report date
Nov 13, 2025
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Cardiol Therapeutics (CRDL) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Cardiol Therapeutics (CRDL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Cardiol Therapeutics (CRDL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Cardiol Therapeutics (CRDL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Cardiol Therapeutics (CRDL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Cardiol Therapeutics (CRDL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Cardiol Therapeutics's revenue and profit?What were the key takeaways from Cardiol Therapeutics’s earnings call?What were the key takeaways from Cardiol Therapeutics's earnings call?What guidance did Cardiol Therapeutics's management provide for the next earnings period?What does Cardiol Therapeutics do and what are its main business segments?Did Cardiol Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Cardiol Therapeutics next quarter?What is the revenue and EPS growth rate for Cardiol Therapeutics year over year?
